BLT 0.00% 2.6¢ benitec biopharma limited

ramifications of inept board / management:

  1. 222 Posts.
    lightbulb Created with Sketch. 6
    - the calamitous IPO
    - the poor share price
    - the loss of confidence of major holder -RA Capital
    - complete miscommunication of 'efficacy' timelines
    - delays continue in trial recruiting and reporting of clinical data
    - PF being sacked without any real explanation
    - no limit at all on the growth of director compensation, travel and expenses etc
    - a few free options in there too to reward management for its 'good performance' - why not while they are at it!

    I think you get the idea. Does anyone on here really think BLT leadership have any credibility left?
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.